These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17658969)

  • 41. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
    Charytan C; Levin N; Al-Saloum M; Hafeez T; Gagnon S; Van Wyck DB
    Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
    Stoves J; Inglis H; Newstead CG
    Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.
    Singh H; Reed J; Noble S; Cangiano JL; Van Wyck DB;
    Clin J Am Soc Nephrol; 2006 May; 1(3):475-82. PubMed ID: 17699248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
    Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB
    Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Abdel-Razeq H; Abbasi S; Saadi I; Jaber R; Abdelelah H
    Drug Des Devel Ther; 2013; 7():939-44. PubMed ID: 24039403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
    Takasawa K; Takaeda C; Wada T; Ueda N
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29596361
    [No Abstract]   [Full Text] [Related]  

  • 47. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?
    Stancu S; Bârsan L; Stanciu A; Mircescu G
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):409-16. PubMed ID: 20019121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iron Treatment Strategies in Dialysis-Dependent CKD.
    Pandey R; Daloul R; Coyne DW
    Semin Nephrol; 2016 Mar; 36(2):105-11. PubMed ID: 27236131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
    Van Wyck DB; Cavallo G; Spinowitz BS; Adhikarla R; Gagnon S; Charytan C; Levin N
    Am J Kidney Dis; 2000 Jul; 36(1):88-97. PubMed ID: 10873877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
    Froessler B; Papendorf D
    Anaesth Intensive Care; 2010 Sep; 38(5):960-2. PubMed ID: 20865896
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
    Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do two intravenous iron sucrose preparations have the same efficacy?
    Rottembourg J; Kadri A; Leonard E; Dansaert A; Lafuma A
    Nephrol Dial Transplant; 2011 Oct; 26(10):3262-7. PubMed ID: 21355067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatal anaphylactic reaction to iron sucrose in pregnancy.
    Mishra A; Dave N; Viradiya K
    Indian J Pharmacol; 2013; 45(1):93-4. PubMed ID: 23543624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
    Solak Y; Atalay H; Guney I; Turkmen K; Kaya E; Turk S
    Ren Fail; 2011; 33(3):307-11. PubMed ID: 21401355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D; Strauss W; Bernard K; Li Z; Urboniene A; Allen LF
    Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Iron supplementation in preterm infants treated with erythropoietin].
    Picaud JC; Putet G; Salle BL; Claris O
    Arch Pediatr; 1999 Jun; 6(6):657-64. PubMed ID: 10394459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
    Schiesser D; Binet I; Tsinalis D; Dickenmann M; Keusch G; Schmidli M; Ambühl PM; Lüthi L; Wüthrich RP
    Nephrol Dial Transplant; 2006 Oct; 21(10):2841-5. PubMed ID: 16891647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.